MedinCell S.A.

ENXTPA:MEDCL Stock Report

Market Cap: €527.1m

MedinCell Future Growth

Future criteria checks 5/6

MedinCell is forecast to grow earnings and revenue by 93.9% and 45.9% per annum respectively while EPS is expected to grow by 70.9% per annum.

Key information

93.9%

Earnings growth rate

70.9%

EPS growth rate

Pharmaceuticals earnings growth17.7%
Revenue growth rate45.9%
Future return on equityn/a
Analyst coverage

Low

Last updated20 Aug 2024

Recent future growth updates

Recent updates

MedinCell S.A. (EPA:MEDCL) Analysts Are More Bearish Than They Used To Be

Jul 05
MedinCell S.A. (EPA:MEDCL) Analysts Are More Bearish Than They Used To Be

Revenues Tell The Story For MedinCell S.A. (EPA:MEDCL) As Its Stock Soars 30%

Apr 26
Revenues Tell The Story For MedinCell S.A. (EPA:MEDCL) As Its Stock Soars 30%

Market Participants Recognise MedinCell S.A.'s (EPA:MEDCL) Revenues Pushing Shares 26% Higher

Jan 09
Market Participants Recognise MedinCell S.A.'s (EPA:MEDCL) Revenues Pushing Shares 26% Higher

The MedinCell (EPA:MEDCL) Share Price Is Up 75% And Shareholders Are Holding On

Mar 02
The MedinCell (EPA:MEDCL) Share Price Is Up 75% And Shareholders Are Holding On

Is MedinCell S.A. (EPA:MEDCL) Popular Amongst Insiders?

Jan 08
Is MedinCell S.A. (EPA:MEDCL) Popular Amongst Insiders?

Earnings and Revenue Growth Forecasts

ENXTPA:MEDCL - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2027883832291
3/31/202639117154
3/31/202527-11334
3/31/202412-25-13-12N/A
12/31/202313-26-18-17N/A
9/30/202314-26-24-23N/A
6/30/202314-29-23-22N/A
3/31/202314-32-22-21N/A
12/31/202213-29-22-21N/A
9/30/202212-27-22-20N/A
6/30/202210-26-23-21N/A
3/31/20228-25-23-21N/A
12/31/20219-22-21-19N/A
9/30/20219-20-18-17N/A
6/30/20219-19-15-14N/A
3/31/20218-19-13-12N/A
12/31/20207-22-12-11N/A
9/30/20205-26-11-10N/A
6/30/20206-25-12-11N/A
3/31/20206-24-13-13N/A
12/31/20196-21-16-16N/A
9/30/20196-19-19-19N/A
6/30/20195-19-18-17N/A
3/31/20194-20-17-16N/A
12/31/20186-17-12-11N/A
9/30/20187-15-8-7N/A
6/30/20188-12-7-6N/A
3/31/20188-10-7-5N/A
3/31/201710-4N/A-3N/A
3/31/201691N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MEDCL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.2%).

Earnings vs Market: MEDCL is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: MEDCL is expected to become profitable in the next 3 years.

Revenue vs Market: MEDCL's revenue (45.9% per year) is forecast to grow faster than the French market (5.8% per year).

High Growth Revenue: MEDCL's revenue (45.9% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MEDCL's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y